Adonis Lorenzana
Pediatric Hematology-Oncology · Grosse Pointe Woods, MINPI 1902890411
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.2%), food and beverage and education — rather than concentrated in one kind of arrangement. Novartis accounts for 64.5% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2022 at $2,002 and has fallen 97.9% since, to $42 in 2025.
Across 63 payments — averaging $51.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Sanofi$367
- Pfizer$151
- Amgen$89
- Novo Nordisk$77
- Jazz Pharmaceuticals Inc.$58
- plus $400 from 20 others
Across 5 payments — averaging $114,372 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$572K
What the payments were for
- Consulting fees$1,87558%
- Food & beverage$1,33341%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 12 | $2,081 |
| Sanofi | 8 | $367 |
| Pfizer | 6 | $151 |
| Amgen | 6 | $89 |
| Novo Nordisk | 4 | $77 |
| Jazz Pharmaceuticals Inc. | 3 | $58 |
| CSL Behring | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| HEMA Biologics, LLC | 2 | $40 |
| Servier Pharmaceuticals LLC | 1 | $25 |
| Emmaus Medical, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Vertex | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Exelixis Inc. | 1 | $18 |
| Kedrion Biopharma, Inc. | 1 | $16 |
| Chiesi USA, Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Fortovia Therapeutics, Inc. | 1 | $15 |
| Clovis Oncology, Inc. | 1 | $14 |
| Puma Biotechnology, Inc. | 1 | $13 |
| Duchesnay USA Incorporated | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Incyte Corporation | 1 | $12 |
| Aurobindo Pharma USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,224 in reported general payments places this provider in the 70th percentile of 84 pediatric hematology-oncology providers in Michigan.
See all pediatric hematology-oncology providers in Michigan →
Other pediatric hematology-oncology in Grosse Pointe Woods
- Steven PipeAnn Arbor$1.3M
- Angela WeyandAnn Arbor$384K
- Michael CallaghanDetroit$374K
- Jordan ShavitAnn Arbor$190K
- Roshni KulkarniLansing$149K
- Ahmar ZaidiDetroit$119K
- Troy QuiggGrand Rapids$101K
- Shawn JobeLansing$94K
- Andrew CampbellAnn Arbor$94K
- Katherine ReglingDetroit$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.